KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Other Operating Expenses (2016 - 2025)

Pacira BioSciences has reported Other Operating Expenses over the past 16 years, most recently at $54.6 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $54.6 million for Q4 2025, up 0.76% from a year ago — trailing twelve months through Dec 2025 was $207.0 million (down 47.04% YoY), and the annual figure for FY2025 was $207.0 million, down 47.04%.
  • Other Operating Expenses for Q4 2025 was $54.6 million at Pacira BioSciences, up from $48.6 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for PCRX hit a ceiling of $216.4 million in Q3 2024 and a floor of $35.2 million in Q1 2021.
  • Median Other Operating Expenses over the past 5 years was $55.0 million (2022), compared with a mean of $64.7 million.
  • Biggest five-year swings in Other Operating Expenses: surged 278.01% in 2024 and later tumbled 77.54% in 2025.
  • Pacira BioSciences' Other Operating Expenses stood at $87.3 million in 2021, then increased by 2.47% to $89.5 million in 2022, then fell by 28.17% to $64.3 million in 2023, then fell by 15.65% to $54.2 million in 2024, then grew by 0.76% to $54.6 million in 2025.
  • The last three reported values for Other Operating Expenses were $54.6 million (Q4 2025), $48.6 million (Q3 2025), and $55.2 million (Q2 2025) per Business Quant data.